Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -0.46% is 90% above its 5-year average of -4.39%, near the high end of its 5-year range (-8.17%–-0.46%).
As of the fiscal period ended Tuesday, June 30, 2026. 84.41% above its 12-month average of -2.95%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-06-30): 1.49%.
RETURN ON ASSETS (ROA)
-0.46%
RETURN ON ASSETS (ROA) AVG TTM
-2.95%
RETURN ON ASSETS (ROA) AVG 3Y
-4.25%
RETURN ON ASSETS (ROA) AVG 5Y
-4.39%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+84.41%
CURRENT VS 3Y AVG
+89.18%
CURRENT VS 5Y AVG
+89.52%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.07%
median of 563 covered companies
CURRENT VS SECTOR MEDIAN
+98.36%
vs the sector median at left
Innovage Holding Corp.
Market Cap
$1.22B
Return on Assets (ROA)
-0.46%
TTM Avg
-2.95%
3Y Avg
-4.25%
5Y Avg
-4.39%
Market Cap
$1.22B
Return on Assets (ROA)
-49.10%
TTM Avg
-49.10%
3Y Avg
-49.10%
5Y Avg
-49.10%
Market Cap
$1.21B
Return on Assets (ROA)
-5.96%
TTM Avg
3.87%
3Y Avg
-6.09%
5Y Avg
-17.05%
Market Cap
$1.22B
Return on Assets (ROA)
5.91%
TTM Avg
1.36%
3Y Avg
-4.42%
5Y Avg
-8.30%
Market Cap
$1.16B
Return on Assets (ROA)
-48.35%
TTM Avg
-102.84%
3Y Avg
-97.55%
5Y Avg
-75.48%
Market Cap
$1.17B
Return on Assets (ROA)
-57.23%
TTM Avg
-57.23%
3Y Avg
-57.23%
5Y Avg
-57.23%
Market Cap
$1.16B
Return on Assets (ROA)
0.69%
TTM Avg
1.67%
3Y Avg
0.18%
5Y Avg
-3.47%
Market Cap
$1.33B
Return on Assets (ROA)
-41.48%
TTM Avg
-39.59%
3Y Avg
-35.47%
5Y Avg
-52.36%
Market Cap
$1.32B
Return on Assets (ROA)
-68.96%
TTM Avg
-38.41%
3Y Avg
-33.02%
5Y Avg
-35.57%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Innovage Holding Corp. (INNV) | $1.22B | -0.46% | -2.95% | -4.25% | -4.39% |
| Kardigan, Inc. (KARD)vs › | $1.22B | -49.10% | -49.10% | -49.10% | -49.10% |
| MannKind Corporation (MNKD)vs › | $1.21B | -5.96% | 3.87% | -6.09% | -17.05% |
| Cronos Group Inc. (CRON)vs › | $1.22B | 5.91% | 1.36% | -4.42% | -8.30% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.16B | -48.35% | -102.84% | -97.55% | -75.48% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.17B | -57.23% | -57.23% | -57.23% | -57.23% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 0.69% | 1.67% | 0.18% | -3.47% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $1.33B | -41.48% | -39.59% | -35.47% | -52.36% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.32B | -68.96% | -38.41% | -33.02% | -35.57% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | -8.93% | -2.89% | -5.64% | -7.78% |
ROA
-0.5%
ROE
-1.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-06-30 | -0.46% |
| 2025-06-30 | -5.44% |
| 2024-06-30 | -3.68% |
| 2023-06-30 | -7.43% |
| 2022-06-30 | -1.16% |
| 2021-06-30 | -8.17% |
| 2020-06-30 | 6.41% |
| 2019-06-30 | 5.39% |
